OrganoClick AB (publ) (ORGC.ST)
SEK 2.75
(-2.48%)
SEK 2.75
(-2.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.95 Million SEK | 127.9% |
| 2022 | -21.19 Million SEK | -89.68% |
| 2021 | -12.92 Million SEK | -187.53% |
| 2020 | -4.4 Million SEK | -39.88% |
| 2019 | -3.08 Million SEK | 72.7% |
| 2018 | -11.43 Million SEK | 35.09% |
| 2017 | -17.43 Million SEK | 29.73% |
| 2016 | -24.7 Million SEK | -33.06% |
| 2015 | -18.72 Million SEK | -45.6% |
| 2014 | -12.89 Million SEK | -7.86% |
| 2013 | -11.84 Million SEK | -51.3% |
| 2012 | -7.85 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 3.52 Million SEK | -1.64% |
| 2024 Q1 | 3.83 Million SEK | 270.88% |
| 2023 Q1 | 3.77 Million SEK | 119.2% |
| 2023 Q3 | 1.03 Million SEK | -69.62% |
| 2023 Q2 | 3.39 Million SEK | -10.27% |
| 2023 FY | - SEK | 127.9% |
| 2023 Q4 | -2.29 Million SEK | -322.91% |
| 2022 FY | - SEK | -89.68% |
| 2022 Q4 | -19.67 Million SEK | -148.78% |
| 2022 Q3 | -7.9 Million SEK | -17.52% |
| 2022 Q2 | -6.73 Million SEK | -61.08% |
| 2022 Q1 | -4.17 Million SEK | 41.87% |
| 2021 Q4 | -7.18 Million SEK | -72.89% |
| 2021 Q1 | -834 Thousand SEK | 85.97% |
| 2021 FY | - SEK | -187.53% |
| 2021 Q2 | -281 Thousand SEK | 66.31% |
| 2021 Q3 | -4.15 Million SEK | -1379.36% |
| 2020 Q2 | 4.79 Million SEK | 458.71% |
| 2020 FY | - SEK | -39.88% |
| 2020 Q3 | -1.84 Million SEK | -138.53% |
| 2020 Q1 | -1.33 Million SEK | 75.88% |
| 2020 Q4 | -5.94 Million SEK | -221.59% |
| 2019 FY | - SEK | 72.7% |
| 2019 Q3 | -2.07 Million SEK | -155.6% |
| 2019 Q2 | 3.72 Million SEK | 364.46% |
| 2019 Q1 | 802 Thousand SEK | 120.44% |
| 2019 Q4 | -5.54 Million SEK | -167.6% |
| 2018 Q4 | -3.92 Million SEK | 18.44% |
| 2018 Q3 | -4.81 Million SEK | -599.58% |
| 2018 Q2 | 963 Thousand SEK | 132.68% |
| 2018 Q1 | -2.94 Million SEK | 59.97% |
| 2018 FY | - SEK | 35.09% |
| 2017 FY | - SEK | 29.73% |
| 2017 Q4 | -7.36 Million SEK | -85.49% |
| 2017 Q3 | -3.96 Million SEK | -313.87% |
| 2017 Q2 | -959 Thousand SEK | 81.56% |
| 2017 Q1 | -5.2 Million SEK | 33.41% |
| 2016 FY | - SEK | -33.06% |
| 2016 Q4 | -7.81 Million SEK | -37.92% |
| 2016 Q3 | -5.66 Million SEK | -30.48% |
| 2016 Q2 | -4.34 Million SEK | 38.48% |
| 2016 Q1 | -7.05 Million SEK | -3.97% |
| 2015 Q1 | -5.07 Million SEK | -132.06% |
| 2015 Q4 | -6.78 Million SEK | -80.43% |
| 2015 Q3 | -3.76 Million SEK | -22.44% |
| 2015 Q2 | -3.07 Million SEK | 39.44% |
| 2015 FY | - SEK | -45.6% |
| 2014 Q4 | -2.18 Million SEK | 22.96% |
| 2014 Q2 | -3.09 Million SEK | 4.58% |
| 2014 Q3 | -2.83 Million SEK | 8.26% |
| 2014 FY | - SEK | -7.86% |
| 2014 Q1 | -3.24 Million SEK | 42.72% |
| 2013 FY | - SEK | -51.3% |
| 2013 Q4 | -5.65 Million SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Svenska Aerogel Holding AB (publ) | -33.47 Million SEK | 117.784% |
| aXichem AB | -15.1 Million SEK | 139.416% |
| HEXPOL AB (publ) | 4.13 Billion SEK | 99.856% |
| Nexam Chemical Holding AB (publ) | -5 Million SEK | 218.846% |
| Polygiene Group AB | -305.6 Million SEK | 101.948% |
| Recyctec Holding AB ser. B | -7.52 Million SEK | 179.134% |
| Triboron International AB (publ) | -5.07 Million SEK | 217.324% |